FeesSafety
Pluang+

Standex appoints Brenna Preisser as new independent director starting Jan 2027, replacing retiring board member.

Company Fundamentals
26 Oct 2026, 23:15 WIB
PRNewsWire
View Source
Bullish
Standex appoints Brenna Preisser as new independent director starting Jan 2027, replacing retiring board member.

Standex International Corporation announced that Brenna D. Preisser, Executive Vice President and President of Brunswick Boat Group, will join its Board of Directors as an independent director effective January 1, 2027. She will replace B. Joanne Edwards, who is retiring after eight years on the board. Preisser brings over 20 years of leadership experience in global manufacturing and will serve on the Compensation and Innovation & Technology Committees. This appointment supports Standex's growth strategy and board succession planning.

Standex International Corporation's board appointment news is presented with Industrials sector market data as context. For readers following Industrials, here is Pluang's market snapshot as of Oct 27, 2026 03:01 WIB: Out of 135 priced US Industrials stocks, 85 rose and 49 fell. Notable movers include TE (T1 Energy Inc.) at USD 2.11 with a 1-day change of -7.86% and 100% buy activity, BAH (Booz Allen Hamilton) at USD 83.84 up 7.05%, and FIX (Comfort Systems USA) at USD 1,241.65 up 6.96%.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
2 hours ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App